KELLY HERRING: Open Payments
NPI 1598409856 · HOMEWOOD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,737 in 104 payments from 17 companies in 2025. Trend: 2023 $129 · 2024 $1,476 · 2025 $1,737
Food & beverage: $1,737
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $285 |
| PFIZER INC. | 12 | $247 |
| Axsome Therapeutics, Inc. | 10 | $221 |
| GlaxoSmithKline, LLC. | 6 | $133 |
| AstraZeneca Pharmaceuticals LP | 7 | $127 |
| Novo Nordisk Inc | 6 | $122 |
| Travere Therapeutics, Inc. | 5 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $85 |
| Exact Sciences Corporation | 5 | $83 |
Products named: VRAYLAR, Auvelity, ELIQUIS, TRELEGY ELLIPTA, Symbravo, Kerendia, AIRSUPRA, CAPLYTA.
Industry payments across AL — which companies pay providers there.
